Biotech Distilled

Substack ↗ Subscribe

Subscribe Substack ↗ About

Research Areas Modalities Phases Targets Track record Movers The Lead Compound

Home › Targets › IL-36α

IL-36α (1 companies · 1 programs)

Companies with an active program directed at IL-36α.

Turn Therapeutics Inc. TTRX

GX-03 — Moderate-to-Severe Eczema Phase 2

Track record About Feedback Report a bug Substack ↗

This website is an encyclopedia of clinical-stage biotech companies, refreshed weekly. For informational and educational use only — not investment advice. Always verify against primary sources before making decisions.